Popular Articles

XenoPort Reports Positive Results From A Phase 2 Trial Of Arbaclofen Placarbil In Spinal Cord Injury Patients With Spasticity
XenoPort, Inc. (Nasdaq:XNPT) announced positive preliminary results from a Phase 2 clinical trial of arbaclofen placarbil (AP), also known as XP19986, for the treatment of patients with spasticity due to spinal cord injury (SCI). Doses of 20 and 30 mg of AP, given twice daily (BID), demonstrated statistically significant improvements compared to placebo for the primary endpoint of the study. AP was well tolerated during the trial.
generic viagra online
Columnist Discusses HIV/AIDS Among Blacks In Washington, D.C.
Columnist George Curry on Tuesday in the Hudson Valley Press discussed how HIV/AIDS is impacting the black community, particularly in Washington, D.C. The piece includes comments from Phill Wilson, CEO of the Black AIDS Institute and C. Virginia Fields, president and CEO of the National Black Leadership Commission on AIDS, who discuss statistics and recommendations to address HIV/AIDS among the black community, including routine HIV testing. Curry writes, "If C. Virginia Fields and other activists get their wish and have [HIV] testing incorporated into routine health testing, that will place a heavier burden on crowded counseling and treatment facilities. But it"s not an insurmountable burden. The question is: Do we have the national will to take on this epidemic?" (7/29).
News of the day
Using Clinical Pathways In Joint Replacement Treatment
Clinical pathways have been used in surgeries since the 1980s, but their nature and usefulness are still subjects of much debate, especially as procedures such as hip and knee joint replacement represent a significant cost to hospitals. Now authors publishing in the open access journal BMC Medicine have concluded that using clinical pathways can effectively improve the quality of the care provided to patients undergoing joint replacement.
Diagnostics

House To Consider Amendment To HHS Bill To Limit Funding To Planned Parenthood Clinics

The House on Friday is expected to pass its fiscal year 2010 Labor-HHS-Education spending bill (HB 3293) after considering several Republican amendments addressing the bill"s price tag and certain policy priorities, CQ Today reports. The bill would appropriate $730.5 billion, making it the largest of the 12 annual appropriations bills. A vote is expected on a GOP amendment, offered by Rep. Mike Pence (R-Ind.), to prohibit family planning funding through the Title X program to Planned Parenthood clinics. Other expected amendments will seek to ban NIH from funding grants to research the HIV/AIDS risks associated with alcohol and substance abuse among sex workers in Asia and to strip language that would lift the ban on federal funding for needle exchange programs (Wolfe, CQ Today, 7/23).In related news, Senate Majority Leader Harry Reid (D-Nev.) on Thursday said the Senate would not vote on a health care reform bill until after Congress returns from its August recess, the New York Times reports (Herszenhorn/Zeleny, New York Times, 7/24). Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women"s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women"s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company. © 2009 The Advisory Board Company. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):